|
WO2020237181A1
|
|
Methods of treating peanut allergy by oral immunotherapy with low-dose maintenance
|
|
US2020368304A1
|
|
Methods for improving the quality of life of a patient with a peanut allergy
|
|
WO2020198024A1
|
|
Systemic allergic response risk assessment in peanut oral immunotherapy
|
|
US2020230206A1
|
|
Peanut oral immunotherapy dosing schedule for missed doses
|
|
WO2020131917A1
|
|
Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
|
|
WO2020037151A1
|
|
Peanut oral immunotherapy with maintenance dose
|
|
WO2020023925A1
|
|
Oral immunotherapy unit dose dispensing systems and methods
|
|
CN111344010A
|
|
Oral immunotherapy method
|
|
AU2018207167A1
|
|
Methods of manufacture of nut flours and formulations for oral immunotherapy
|
|
US2016051639A1
|
|
Egg protein formulations and methods of manufacture thereof
|
|
US2014271721A1
|
|
Peanut formulations and uses thereof
|
|
AU2014240404A1
|
|
Manufacture of peanut formulations for oral desensitization
|
